223 related articles for article (PubMed ID: 35436671)
1. Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors.
Wang Y; Chen H; Zha X
Eur J Med Chem; 2022 Jun; 236():114363. PubMed ID: 35436671
[TBL] [Abstract][Full Text] [Related]
2. The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5).
Zhou Y; Zhang H; He B; Du J; Lin H; Cerione RA; Hao Q
J Biol Chem; 2012 Aug; 287(34):28307-14. PubMed ID: 22767592
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial Infections.
Heinonen T; Ciarlo E; Théroude C; Pelekanou A; Herderschee J; Le Roy D; Roger T
Front Immunol; 2018; 9():2675. PubMed ID: 30515162
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.
Fiorentino F; Castiello C; Mai A; Rotili D
J Med Chem; 2022 Jul; 65(14):9580-9606. PubMed ID: 35802779
[TBL] [Abstract][Full Text] [Related]
6. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.
Fischer F; Gertz M; Suenkel B; Lakshminarasimhan M; Schutkowski M; Steegborn C
PLoS One; 2012; 7(9):e45098. PubMed ID: 23028781
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.
Maurer B; Rumpf T; Scharfe M; Stolfa DA; Schmitt ML; He W; Verdin E; Sippl W; Jung M
ACS Med Chem Lett; 2012 Dec; 3(12):1050-3. PubMed ID: 24900427
[TBL] [Abstract][Full Text] [Related]
8. Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization.
Mahlknecht U; Ho AD; Letzel S; Voelter-Mahlknecht S
Cytogenet Genome Res; 2006; 112(3-4):208-12. PubMed ID: 16484774
[TBL] [Abstract][Full Text] [Related]
9. Role of the Substrate Specificity-Defining Residues of Human SIRT5 in Modulating the Structural Stability and Inhibitory Features of the Enzyme.
Yu J; Haldar M; Mallik S; Srivastava DK
PLoS One; 2016; 11(3):e0152467. PubMed ID: 27023330
[TBL] [Abstract][Full Text] [Related]
10. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
Gertz M; Steegborn C
Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
[TBL] [Abstract][Full Text] [Related]
11. Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications.
Cen Y; Youn DY; Sauve AA
Curr Med Chem; 2011; 18(13):1919-35. PubMed ID: 21517779
[TBL] [Abstract][Full Text] [Related]
12. Shedding light on structure, function and regulation of human sirtuins: a comprehensive review.
Sharma A; Mahur P; Muthukumaran J; Singh AK; Jain M
3 Biotech; 2023 Jan; 13(1):29. PubMed ID: 36597461
[TBL] [Abstract][Full Text] [Related]
13. Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5.
Suenkel B; Valente S; Zwergel C; Weiss S; Di Bello E; Fioravanti R; Aventaggiato M; Amorim JA; Garg N; Kumar S; Lombard DB; Hu T; Singh PK; Tafani M; Palmeira CM; Sinclair D; Mai A; Steegborn C
J Med Chem; 2022 Oct; 65(20):14015-14031. PubMed ID: 36228194
[TBL] [Abstract][Full Text] [Related]
14. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
[TBL] [Abstract][Full Text] [Related]
15. Cloning, chromosomal characterization and FISH mapping of the NAD(+)-dependent histone deacetylase gene sirtuin 5 in the mouse.
Voelter-Mahlknecht S; Mahlknecht U
Int J Oncol; 2013 Jul; 43(1):237-45. PubMed ID: 23673559
[TBL] [Abstract][Full Text] [Related]
16. Thiosuccinyl peptides as Sirt5-specific inhibitors.
He B; Du J; Lin H
J Am Chem Soc; 2012 Feb; 134(4):1922-5. PubMed ID: 22263694
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.
Suenkel B; Fischer F; Steegborn C
Bioorg Med Chem Lett; 2013 Jan; 23(1):143-6. PubMed ID: 23195732
[TBL] [Abstract][Full Text] [Related]
18. Screening Analysis of Sirtuins Family Expression on Anti-Inflammation of Resveratrol in Endothelial Cells.
Yu H; Pan W; Huang H; Chen J; Sun B; Yang L; Zhu P
Med Sci Monit; 2019 Jun; 25():4137-4148. PubMed ID: 31158122
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin regulation in aging and injury.
Poulose N; Raju R
Biochim Biophys Acta; 2015 Nov; 1852(11):2442-55. PubMed ID: 26303641
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors.
Yang L; Ma X; He Y; Yuan C; Chen Q; Li G; Chen X
Sci China Life Sci; 2017 Mar; 60(3):249-256. PubMed ID: 27858336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
